Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection

This article has 1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Improved understanding of immunity offered by the antibodies developed against SARS-CoV-2 is critical. Our study aimed at longitudinal analysis of presence and persistence of neutralizing antibodies over ten months in mild and moderately-severe COVID-19 recovered patients using two immunoassays.

Article Summary Line

Neutralizing IgG antibody persistency was demonstrated in 63.3% of the subjects (19 out of 30) at ten months post-infection with zero re-infections.

Related articles

Related articles are currently not available for this article.